Millennium Management’s Polaryx Therapeutics Inc PLYX Stock Holding History

Millennium Management’s Portfolio PLYX Stock Details PLYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$964K	Buy	+127,525	New	+$824K	﹤0.01%	4421

Other funds holding PLYX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Millennium Management's PLYX Position: Q1 2026 in Review

Millennium Management opened a new position in Polaryx Therapeutics Inc (PLYX) in Q1 2026: 127,525 shares worth $964K. The stake represents ﹤0.01% of the portfolio and ranks #4421 among its holdings.

14 funds tracked by Wall St. Rank hold PLYX as of Q1 2026.

Millennium Management held 127,525 shares of Polaryx Therapeutics Inc worth $964K as of Q1 2026.
Polaryx Therapeutics Inc was a new Millennium Management position in Q1 2026.
Polaryx Therapeutics Inc made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4421 holding.
14 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.